Welcome to our dedicated page for Adtalem Global Ed SEC filings (Ticker: ATGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Covista Inc. SEC filings document the company’s transition from Adtalem Global Education Inc. and its ongoing disclosures as a healthcare education company. Recent 8-K filings cover certificate and bylaw amendments for the name change, the related ticker change from ATGE to CVSA, academic and financial results, enrollment trends, guidance updates, and Regulation FD investor materials.
The filings also describe capital-structure and governance matters, including credit agreement amendments, term loan refinancing, senior secured notes redemption, share repurchase authorizations, and annual meeting vote results. These records frame the company’s public-company reporting around healthcare education operations, institutional performance, capital allocation, debt arrangements, and shareholder governance.
Adtalem Global Education (ATGE) Form 4: Director Ms. O’Keefe was granted 1,445 restricted stock units representing common stock on 11/12/2025 at a reference price of $96.86. The award vests 100% on the one-year anniversary of the transaction date.
Following the reported grant, beneficial ownership stands at 16,597 shares, held directly. This is a routine director equity award intended to align compensation with shareholder interests.
Adtalem Global Education (ATGE) reported an insider equity award on Form 4. The Chief Corporate Affairs Officer acquired 2,226 shares of common stock on 11/12/2025 coded “A,” reflecting a grant of restricted stock units at a reference price of $96.86 per share.
The award consists of RSUs that convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026. Following the transaction, the reporting person beneficially owned 2,226 shares, held directly.
Adtalem Global Education (ATGE) Form 4: Lead Independent Director (and Director) reported equity transactions. On 11/12/2025, the reporting person acquired 1,445 shares of common stock in the form of restricted stock units (RSUs) at a reference value of $96.86 per unit, reflecting the closing price used to determine the award size. On 11/13/2025, 526 shares were disposed of to satisfy tax withholding upon vesting at $96.26 per share.
Following these transactions, the reporting person beneficially owns 101,364 shares, held directly. The RSUs vest 100% on the one-year anniversary of the grant date.
Adtalem Global Education (ATGE) reported insider equity activity by its President, Medical and Vet. On 11/12/2025, the officer acquired 2,613 shares reported as restricted stock units (RSUs) at a reported price of $96.86, increasing direct holdings to 13,958 shares. On 11/13/2025, 407 shares were withheld at $96.26 to satisfy taxes upon vesting of prior RSUs, leaving 13,551 shares directly owned.
The filing notes the RSUs convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026.
Adtalem Global Education (ATGE) director Form 4: A board member reported equity changes tied to director compensation and routine tax withholding. On 11/12/2025, the director received 1,445 restricted stock units at a reference price of $96.86; these stock units vest 100% on the one year anniversary of the transaction date. On 11/13/2025, 421 shares were withheld at $96.26 to satisfy taxes from previously vested awards.
Following these transactions, the director’s direct ownership stands at 16,303 shares.
Adtalem Global Education (ATGE) reported a director’s routine equity transactions on Form 4. On 11/12/2025, the director received 1,445 restricted stock units, determined using the $96.86 closing price, which vest 100% one year from the grant date. On 11/13/2025, 425 shares were withheld to satisfy taxes upon the vesting of earlier RSU awards at a reference price of $96.26.
Following these transactions, the director directly beneficially owns 17,481 shares.
Adtalem Global Education (ATGE): A company director reported Form 4 transactions. On 11/12/2025, the director received 1,445 restricted stock units, which vest 100% one year from the grant date. The grant size was determined using the ATGE closing price of $96.86 on November 12, 2025.
On 11/13/2025, 344 shares were withheld to satisfy tax obligations upon the vesting of previously awarded RSUs at a price of $96.26. Following these transactions, the director reported 8,562 shares directly owned after the grant and 8,218 shares directly owned after the tax withholding.
Adtalem Global Education (ATGE) disclosed an insider equity transaction. The company’s CHRO reported acquiring 1,673 common shares labeled as restricted stock units on 11/12/2025 at a reported price of $96.86. Following this transaction, the officer directly beneficially owns 10,276 shares.
The filing notes these are restricted stock units that convert one-for-one into common stock and vest in three equal installments beginning 11/12/2026.
Adtalem Global Education (ATGE) reported insider activity by its SVP–Chief Marketing Officer. On 11/12/2025, the officer received 1,750 restricted stock units at a stated price of $96.86. These RSUs vest in three equal installments beginning on November 12, 2026.
On 11/13/2025, 343 shares were withheld (Code F) to satisfy taxes upon vesting of previously awarded RSUs at $96.26. After these entries, the officer directly owns 20,584 shares.
Adtalem Global Education (ATGE) reported a Form 4 for its VP, Chief Accounting Officer. On 11/12/2025, the officer acquired 890 shares of common stock at a reported price of $96.86, noted as restricted stock units that convert one-for-one. On 11/13/2025, 94 shares were withheld at $96.26 to cover taxes upon vesting of prior RSUs.
The RSUs vest in three equal installments beginning on November 12, 2026. Following the transactions, directly owned shares were 5,697. This filing reflects routine equity compensation activity and associated tax withholding by a company officer.